BACKGROUND: Aboriginal and Torres Strait Islander people are disproportionately affected by hepatitis B virus (HBV) infection. A proposed mismatch between standard vaccines and the HBV/C4 sub-genotype prevalent in Aboriginal people in the Northern Territory (NT) may reduce vaccine effectiveness. AIMS: To determine HBV prevalence in the NT by Indigenous status and to explore patterns of immunity following implementation of universal vaccination, using a large longitudinal diagnostic dataset. METHODS: A retrospective analysis of all available HBV serology results in the NT from 1991 to 2011 was conducted, with HBV prevalence and vaccination status analysed according to adigenous status, age and sex using individuals' patterns of HBsAg, anti-H...
OBJECTIVE: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
The Australian National Hepatitis B Strategy 2010-13 outlines five priority areas for developing a c...
Objective: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
<div><p>Background</p><p>Indigenous populations globally are disproportionately affected by chronic ...
Background A higher prevalence of chronic hepatitis B (CHB) has been reported in Aboriginal and Torr...
BACKGROUND: In Australia, higher rates of chronic hepatitis B (HBsAg) have been reported among Abori...
Background: In Australia, higher rates of chronic hepatitis B (HBsAg) have been reported among Abori...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
Background: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
Abstract Background Chronic hepatitis B is a public health concern in Aboriginal communities in the ...
OBJECTIVE: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
The Australian National Hepatitis B Strategy 2010-13 outlines five priority areas for developing a c...
Objective: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
<div><p>Background</p><p>Indigenous populations globally are disproportionately affected by chronic ...
Background A higher prevalence of chronic hepatitis B (CHB) has been reported in Aboriginal and Torr...
BACKGROUND: In Australia, higher rates of chronic hepatitis B (HBsAg) have been reported among Abori...
Background: In Australia, higher rates of chronic hepatitis B (HBsAg) have been reported among Abori...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
Background: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
Objective: Hepatitis B virus (HBV) infection remains an important cause of morbidity and mortality i...
Abstract Background Chronic hepatitis B is a public health concern in Aboriginal communities in the ...
OBJECTIVE: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
The Australian National Hepatitis B Strategy 2010-13 outlines five priority areas for developing a c...
Objective: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...